OPINION Today, the demand for new board members is immense. Start-up companies, including those in the biopharma industry, are aggressively pursuing listings, which requires them to add independent and diverse members. Once a company is public, investors need to cycle

In a promising sign, boards are increasingly eager to add more diversity to their ranks, as they recognize that it makes their organizations more competitive and resilient, more attractive to investors and talent. As they search for new diverse talent,

The biopharmaceutical industry faces many challenges due to the current global health crisis. Quarantines and social distancing measures have impacted operations in ways never imagined. Senior executives and leaders are navigating through contingency plans, employee safety measures and remote work

“To enable transformational recruitment for organizations, in a changing landscape, requires going the extra mile to create comfort for the clients making decisions.” ARNALDO DE LISIO, CATALYST ADVISORS Arnaldo De Lisio, one of our partners, discusses what it means to

In the biopharma industry, the recruiting market is highly competitive and experienced senior leaders are in high demand. Companies invest a lot of time and money in the recruitment process, and critical executive hires are needed to accelerate pipelines and